This SPARK Studio session will provide a high-level overview of the U.S. FDA regulatory framework for medical devices, focusing on key requirements for manufacturers. Topics will cover FDA classification system (Class I, II and III), product code selection and premarket pathways (i.e. 510(k), PMA, De Novo). Attendees will gain insights into the submission process, predicate device selection, and ongoing compliance obligations under FDA guidelines.
Alexandra (Alex) Schardt, Manager, Regulatory Affairs for MCRA will be hosting this talk. Alex has over 7 years of experience in the biotechnology industry and medical device regulatory affairs. Alex is RAC-certified in medical device regulatory affairs. Before joining MCRA in 2021, Alexandra worked in viral vector product development at a privately hed biotech company. Alexdra received her Bachelor of Science for Gettysburg College in Biochemistry and Molecular Biology. Alexandra also received a Master of Science in Biotechnology from Johns Hopkins University, concentrated in Regulatory Affairs.